Doses of olanzapine, risperidone, and haloperidol used in clinical practice: Results of a prospective pharmacoepidemiologic study
- 31 May 2000
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 22 (5) , 583-599
- https://doi.org/10.1016/s0149-2918(00)80046-6
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The Safety of Olanzapine Compared With Other Antipsychotic DrugsThe Journal of Clinical Psychiatry, 2000
- Risperidone and olanzapineInternational Clinical Psychopharmacology, 1998
- Olanzapine versus Placebo and HaloperidolNeuropsychopharmacology, 1996
- Can overall results of clinical trials be applied to all patients?The Lancet, 1995
- Risperidone in the Treatment of Patients with Chronic Schizophrenia: a Multi-National, Multi-Centre, Double-Blind, Parallel-Group Study versus HaloperidolThe British Journal of Psychiatry, 1995
- RisperidoneDrugs, 1994
- Risperidone in the treatment of schizophreniaAmerican Journal of Psychiatry, 1994
- Drug Utilisation Studies as Tools in Health EconomicsPharmacoEconomics, 1994
- The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patientsActa Psychiatrica Scandinavica, 1987
- A plea for the ?naturalistic? study of medicinesEuropean Journal of Clinical Pharmacology, 1974